Centene Overview
- Year Founded
-
1984

- Status
-
Public
- Employees
-
60,500

- Stock Symbol
-
CNC

- Investments
-
50
- Share Price
-
$29.14
- (As of Thursday Closing)
Centene General Information
Description
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Contact Information
Website
www.centene.comCorporate Office
- Centene Plaza
- 7700 Forsyth Boulevard
- Saint Louis, MO 63105
- United States
Corporate Office
- Centene Plaza
- 7700 Forsyth Boulevard
- Saint Louis, MO 63105
- United States
Centene Timeline
Centene Stock Performance
As of 17-Jul-2025, Centene’s stock price is $29.14. Its current market cap is $14.5B with 498M shares.
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$29.14 | $30.41 | $28.92 - $80.59 | $14.5B | 498M | 8.78M | $6.74 |
Centene Financials Summary
As of 31-Mar-2025, Centene has a trailing 12-month revenue of $169B.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 32,959,806 | 30,722,722 | 38,440,056 | 51,046,957 |
Revenue | 169,284,000 | 163,071,000 | 153,999,000 | 144,547,000 |
EBITDA | 6,471,000 | 6,200,000 | 5,616,000 | 4,057,000 |
Net Income | 3,453,000 | 3,305,000 | 2,702,000 | 1,202,000 |
Total Assets | 87,044,000 | 82,445,000 | 84,641,000 | 76,870,000 |
Total Debt | 18,320,000 | 19,429,000 | 18,877,000 | 21,333,000 |
Centene Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Centene Comparisons
Industry
Financing
Details
Centene Competitors (10)
One of Centene’s 10 competitors is Humana, a Corporation company based in Louisville, KY.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Humana | Corporation | Louisville, KY | ||||
The Cigna Group | Corporation | Bloomfield, CT | ||||
Oscar Health | Formerly VC-backed | New York, NY | ||||
Highmark | Formerly VC-backed | Pittsburgh, PA | ||||
AIG Europe | Corporation | Oslo, Norway |
Centene Patents
Centene Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240006060-A1 | Machine learning based systems and methods for classifying electronic data and generating messages | Pending | 30-Jun-2022 | ||
US-20210265065-A1 | Systems and methods for analyzing multiple variables in dynamic resource distribution | Pending | 24-Feb-2020 | ||
US-11615793-B1 | Voice assistant configured to leverage information from sensing devices | Active | 02-Jan-2019 | ||
US-20180341889-A1 | Entity level classifier using machine learning | Inactive | 25-May-2017 | ||
US-9721066-B1 | Smart fitness tracker | Inactive | 29-Apr-2016 |
Centene Signals
Centene Investments & Acquisitions (50)
Centene’s most recent deal was a Later Stage VC with Main Street Health for . The deal was made on 08-Oct-2023.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Main Street Health | 08-Oct-2023 | Later Stage VC | Clinics/Outpatient Services | ||
Hazel Health | 27-Oct-2022 | Later Stage VC | Clinics/Outpatient Services | ||
Magellan Health | 04-Jan-2022 | Merger/Acquisition | Managed Care | ||
Wayspring | 28-Sep-2021 | Later Stage VC | Clinics/Outpatient Services | ||
Circle Health Group | 14-Jul-2021 | Merger/Acquisition | Hospitals/Inpatient Services |
Centene ESG
Risk Overview
Risk Rating
Updated June, 25, 2025
14.08 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,697
Rank
Percentile

Healthcare
Industry
of 562
Rank
Percentile

Managed Health Care
Subindustry
of 16
Rank
Percentile

Centene Exits (13)
Centene’s most recent exit was on 14-Jul-2021 from Circle Health Group. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Circle Health Group | 14-Jul-2021 | Completed |
|
||
PANTHERx Rare | 30-Dec-2020 | Completed |
|
||
Apixio | 08-Dec-2020 | Completed |
|
||
Availity Clinical Solutions | 14-Sep-2020 | Completed |
|
||
Babylon Health | 01-Aug-2019 | Later Stage VC | Completed |
|
Centene Affiliates
Subsidiaries (46)
Name | Industry | Location | Year Founded |
---|---|---|---|
Mauli Ola Health And Wellness | Honolulu, HI | 2019 | |
Sunshine Health Holding | Saint Louis, MO | 2019 | |
Envolve Total Vision | Rocky Mount, NC | 2018 | |
Ambetter Of Peach State | Atlanta, GA | 2018 | |
Envolve Dental Ipa Of New York | New York, NY | 2018 |
Centene FAQs
-
When was Centene founded?
Centene was founded in 1984.
-
Where is Centene headquartered?
Centene is headquartered in Saint Louis, MO.
-
What is the size of Centene?
Centene has 60,500 total employees.
-
What industry is Centene in?
Centene’s primary industry is Life and Health Insurance.
-
Is Centene a private or public company?
Centene is a Public company.
-
What is Centene’s stock symbol?
The ticker symbol for Centene is CNC.
-
What is the current stock price of Centene?
As of 17-Jul-2025 the stock price of Centene is $29.14.
-
What is the current market cap of Centene?
The current market capitalization of Centene is $14.5B.
-
What is Centene’s current revenue?
The trailing twelve month revenue for Centene is $169B.
-
Who are Centene’s competitors?
Humana, The Cigna Group, Oscar Health, Highmark, and AIG Europe are some of the 10 competitors of Centene.
-
What is Centene’s annual earnings per share (EPS)?
Centene’s EPS for 12 months was $6.74.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »